Welcome to
On Feet Nation
goditac499 Online
yousuf Online
Diane Online
Thomas Shaw Online
Michael Online
Posted by Helen on October 16, 2024 at 2:27am 0 Comments 0 Likes
Posted by Samuel on October 16, 2024 at 2:27am 0 Comments 0 Likes
Posted by EMed Healthtech on October 16, 2024 at 2:27am 0 Comments 0 Likes
During COVID, technology helped meet basic needs and made tasks like doctor visits more accessible. The pandemic increased the adoption of technology in healthcare. However, the shift to virtual care has reduced post-pandemic. Challenges include lack of awareness and trust, and fragmented technology systems. Integrated healthcare solutions aim to improve communication, streamline services,…
ContinueRoots Analysis has done a detailed study on Large Volume Wearable Injectors Market (5th Edition), 2020-2030: Focus on Bolus, Basal and Continuous Delivery Devices.”, covering key aspects of the industry’s current trends and identifying potential future growth opportunities.
To order this 540+ page report, which features 175+ figures and 200+ tables, please visit this -…
ContinueAdded by Kevin Doe on March 31, 2021 at 2:03am — No Comments
Large Volume Wearable Injectors have made it convenient to self-administer drugs in the home care setting, providing substantial cost benefits, improving medication adherence and reducing the risk of dosing errors, microbial contamination and needle-stick injuries; in fact, these drug delivery devices can prove to be potential vehicles for drug administration in disease outbreaks / pandemics (such as the one being faced due to the novel corona virus / COVID-19).
Roots Analysis is…
ContinueAdded by Kevin Doe on March 31, 2021 at 2:00am — No Comments
Roots Analysis has done a detailed study on “Microbial Contract Biomanufacturing Market, 2020-2030” covering key aspects of the industry and identifying potential future growth opportunities.
To order this 320+ page report, which features 150+ figures and 150+ tables, please visit this - https://www.rootsanalysis.com/reports/microbial-contract-biomanufacturing-market.html
Key…
ContinueAdded by Kevin Doe on March 30, 2021 at 2:08am — No Comments
Benefits offered by microbial biomanufacturing, such as low production costs and faster development timelines, have led many innovators to adopt these platforms for next generation biologics, offering lucrative opportunities for CMOs / CDMOs
Roots Analysis is pleased to announce the publication of its recent study, titled, “Microbial Contract Biomanufacturing Market, 2020-2030.
The report features an extensive study of the current market landscape and future opportunities…
ContinueAdded by Kevin Doe on March 30, 2021 at 2:02am — No Comments
The growing pipeline of biologics that can be produced in microbial systems, such as antibody fragments and plasmid-based therapies, is anticipated to offer lucrative opportunities to service providers serving this niche, but growing market segment
London
Roots Analysis has announced the addition of the “Microbial Contract Biomanufacturing Market, 2020-2030” report to its list of offerings.
Despite mammalian cell cultures being the preferred manufacturing approach for…
ContinueAdded by Kevin Doe on March 30, 2021 at 1:57am — No Comments
There is a growing body of evidence supporting the vast applicability and superiority of treatment outcomes of stem cell therapies, compared to conventional treatment options. In fact, the unmet needs within this domain have spurred the establishment of many start-ups in recent years. Further, recent studies suggest that mesenchymal stem cells mesenchymal stem cells can be effectively used to improve patients' resistance to the SARS-CoV-2 virus induced pneumonia leading to speedy…
ContinueAdded by Kevin Doe on March 30, 2021 at 1:54am — No Comments
Roots Analysis has done a detailed study on “Global Stem Cells Market: Focus on Clinical Therapies, 2020–2030 (Based on Source (Allogeneic, Autologous); Origin (Adult, Embryonic); Type (Hematopoietic, Mesenchymal, Progenitor); Lineage (Amniotic Fluid, Adipose Tissue, Bone Marrow, Cardiosphere, Chondrocytes, Corneal Tissue, Cord Blood, Dental Pulp, Neural Tissue Placenta, Peripheral Blood, Stromal Cells); and Potency (Multipotent, Pluripotent))”covering key aspects of the industry’s evolution…
ContinueAdded by Kevin Doe on March 30, 2021 at 1:50am — No Comments
With multiple approved products, the field of stem cell therapies has gained substantial momentum over the last decade; several innovator companies are currently progressing their proprietary therapy candidates with cautious optimism. In fact, recent studies suggest that mesenchymal stem cells have the potential to end the Coronavirus (COVID-19) pandemic.
Roots Analysis is pleased to announce the publication of its recent study, titled, “Global Stem Cells Market: Focus on Clinical…
ContinueAdded by Kevin Doe on March 30, 2021 at 1:46am — No Comments
Screening small molecule fragments has made it possible to identify pharmacological leads against otherwise hard to target hotspots on biomolecules, such as allosteric sites, rendering this approach a valuable alternative method of drug discovery
Roots Analysis is pleased to announce the publication of its recent study, titled, “Fragment-based Drug Discovery Market: Library and Service Providers, 2020-2030”
The report features an extensive study of the current market landscape,…
ContinueAdded by Kevin Doe on March 26, 2021 at 2:07am — No Comments
Traditional drug discovery is associated with exorbitant investments, prolonged lead evolution timelines and high attrition rates; the fragment-based approach is a versatile technique, enabling researchers to mitigate a number of existing challenges
London
Roots Analysis has announced the addition of the “Fragment-based Drug Discovery Market: Library and Service Providers, 2020-2030” report to its list of offerings.
According to experts in this field, fragment-based drug…
ContinueAdded by Kevin Doe on March 26, 2021 at 2:04am — No Comments
Roots Analysis has done a detailed study on “HPAPI and Cytotoxic Drugs Manufacturing (3rd Edition) 2020-2030.” covering key aspects of the industry’s evolution and identifying potential future growth opportunities.
To order this 300+ page report, which features 75+ figures and 150+ tables, please visit this -…
ContinueAdded by Kevin Doe on March 26, 2021 at 2:00am — No Comments
Manufacturing highly potent drug products is technically and financially demanding; as a result, drug manufacturers are becoming increasingly reliant on contract service providers
Roots Analysis is pleased to announce the publication of its recent study, titled, “HPAPI and Cytotoxic Drugs Manufacturing (3rd Edition) 2020-2030.”
The report features an extensive study of the current market landscape and future opportunities associated with the contract manufacturing of HPAPIs and…
ContinueAdded by Kevin Doe on March 26, 2021 at 1:55am — No Comments
Several big pharma companies are known to outsource more than half of their clinical-stage oligonucleotide manufacturing operations. Anticipating a sharp rise in demand, oligonucleotide manufacturers are increasingly consolidating their portfolios, building new capabilities and expanding their respective capacities, mostly through acquisitions, in order to gain a competitive edge.
To order this 300+ page report, which features 140+ figures and 190+ tables, please visit this -…
ContinueAdded by Kevin Doe on March 25, 2021 at 2:17am — No Comments
Roots Analysis has done a detailed study on “Oligonucleotide Synthesis, Modification and Purification Services Market: Focus on Research, Diagnostic and Therapeutic Applications, 2020-2030” covering key aspects of the industry’s evolution and identifying potential future growth opportunities.
To order this 300+ page report, which features 140+ figures and 190+ tables, please visit this -…
ContinueAdded by Kevin Doe on March 25, 2021 at 2:10am — No Comments
The applications of oligonucleotides are vast, even beyond the life science / pharma sector; however, owing to complexities associated with the synthesis and processing of these molecules, such operations are usually outsourced to capable CMOs
Roots Analysis is pleased to announce the publication of its recent study, titled, “Oligonucleotide Synthesis, Modification and Purification Services Market: Focus on Research, Diagnostic and Therapeutic Applications, 2020-2030
The report…
ContinueAdded by Kevin Doe on March 25, 2021 at 2:05am — No Comments
The rapidly growing demand for oligonucleotides, coupled to complex manufacturing procedures and high capital investments required for setting up manufacturing facilities, has generated a range of new opportunities for custom manufacturers
London
Roots Analysis has announced the addition of the “Oligonucleotide Synthesis, Modification and Purification Services Market: Focus on Research, Diagnostic and Therapeutic Applications, 2020-2030” report to its list of…
ContinueAdded by Kevin Doe on March 25, 2021 at 2:02am — No Comments
To order this detailed 300+ page report, please visit this - https://www.rootsanalysis.com/reports/view_document/patient-recruitment-and-retention-services-market/245.html
Key Inclusions
A detailed assessment of the current market landscape, including information on drug developer(s),
A detailed assessment of the current market landscape of…
Added by Kevin Doe on March 25, 2021 at 1:58am — No Comments
A steadily increasing demand for study participants and the complexities associated with patient enrollment has imposed a significant burden on drug developer companies, prompting them to enlist the services of specialty service providers. Presently, close to 140 companies are actively offering patient recruitment and retention services. Majority of these players possess vast service portfolios and utilize diverse patient outreach methods to recruit study participants across different…
ContinueAdded by Kevin Doe on March 25, 2021 at 1:54am — No Comments
Roots Analysis has done a detailed study Patient Recruitment and Retention Services Marker, 2019-2030.”
, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.
To order this 300+ page report, which features 90+ figures and 140+ tables, please visit this -…
ContinueAdded by Kevin Doe on March 25, 2021 at 1:51am — No Comments
A steadily increasing demand for participants in clinical research studies, coupled to the complexities associated with patient enrolment, have prompted drug / therapy developers to outsource this process to specialty service providers
Roots Analysis is pleased to announce the publication of its recent study, titled, “Patient Recruitment and Retention Services Marker, 2019-2030.”
The report offers a comprehensive study of the current scenario and future potential of the players…
ContinueAdded by Kevin Doe on March 25, 2021 at 1:47am — No Comments
© 2024 Created by PH the vintage. Powered by